Article

IL-17A Not Linked to Behçet's Disease

Author(s):

Researchers did not find any upregulation in the cytokine interleukin 17 A (IL-17A) in active patients with Behçet's disease.

In a study published in PostÄ™py, researchers did not find any upregulation in the cytokine interleukin 17 A (IL-17A) in active patients with Behçet’s disease (BD).

By their nature, studies showing a lack of a connection between a particular cytokine and a condition such as BD aren’t exactly the sexiest. But in this case, the finding contradicts some related (but not identical) research showing a potential link. And the continued mysterious nature of the etiology and pathogenesis of BD makes the finding of particular interest.

An increased expression of IL-17 has been seen in some inflammatory rheumatic diseases such as systemic sclerosis, rheumatoid arthritis, systemic lupus erythematous (SLE), and osteoarthritis (OA). BD gives indications of being similar to these inflammatory conditions, given that it is characterized by recurrent oral aphthous ulcers, genital ulcers, skin lesions, and uveitis. It may also present with arthritis, arthralgia, gastrointestinal tract lesions, and vascular lesions in the large or small vessels. But do autoimmune mechanisms play a role in BD’s pathogenesis?

In the current study, 76 active BD patients (56 females, 20 males) were diagnosed according to the criteria of the International Study Group for BD. Seventy stable BD patients (36 females, 34 males) joined the study as a control group.

Patients who had at least one criterion like oral ulcers, genital ulcers, anterior uveitis, posterior or panuveitis, cutaneous manifestations, pathergy test positivity criteria were accepted to be active BD patients. Peripheral venous blood samples were received from active BD patients and control group after 8 hours of fasting. There was statistically no difference between serum IL-17A levels of active and inactive BD patients (p > 0.05).

“We did not observe an increase in serum IL-17A levels in patients who had oral ulcers compared with patients who do not have oral ulcers, patients who had genital ulcers compared with patients who do not have genital ulcers, patients who had skin involvement (erythema nodosum, papulopustular eruption) compared with patients who do not have any skin involvement, patients who had arthralgia/arthritis compared with patients who do not have arthralgia/arthritis, patients who were taking medications compared with patients who were not taking any medications,” the researchers observed. “There were no patients with uveitis. And there were not enough patients with the gastrointestinal, central nervous system, vascular involvement for statistical assessment.”

Alongside their finding, the researchers mused about whether BD is an autoinflammatory disease at all, because they lack mutations that are seen in many autoinflammatory diseases. “Behçet disease attacks are more frequent than autoinflammatory disease attacks and its severity decreases with time,” they conclude. “Eventually these findings demonstrate that BD is not an autoinflammatory disease.”

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Omega-3 Supplements for Rosacea and Other Tips for Dermatologists, with Andrea Murina, MD
© 2024 MJH Life Sciences

All rights reserved.